Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03782103 · ClinicalTrials.gov registry record · Phase 3
In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)
A Phase 3 study of Surgical Skin Preparation, sponsored by Zurex Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT03782103 is a Phase 3 study of Surgical Skin Preparation that has completed, run by Zurex Pharma. The registered enrollment target is 156 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03782103, a Phase 3 study of Surgical Skin Preparation, has completed, sponsored by Zurex Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.
Conditions Studied
Interventions
- DRUG ChloraPrep
- DRUG ZuraPrep Clear Solution
- DRUG ZuraPrep Vehicle
Study Locations (1)
Virginia
- Microbac Laboratories, Inc. - Sterling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2019-09-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03782103
The ClinicalTrials.gov registry entry for NCT03782103 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zurex Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Skin Preparation appearing as the primary indexed condition, and to 3 interventions - of which ChloraPrep is the first listed.
NCT03782103 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03782103 about?
NCT03782103 is a clinical study titled "In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)". The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.
What is the current status of trial NCT03782103?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 156 participants. The study started on 2019-01-25. Estimated completion is 2019-09-26.
What conditions does trial NCT03782103 study?
This clinical trial studies the following conditions: Surgical Skin Preparation.
What interventions are being tested in trial NCT03782103?
The interventions under investigation include: ChloraPrep (DRUG), ZuraPrep Clear Solution (DRUG), ZuraPrep Vehicle (DRUG).
Who is sponsoring clinical trial NCT03782103?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03782103 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Skin Preparation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.